International Clinical Trial: A Single-center Prospective Cohort Study to Evaluate the Efficacy and Safety of Methotrexate Injection (Metoject(R)) in Subjects with Moderateto-Severe Immune Checkpoint Inhibitor-Related Psoriasis

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126437) titled 'A Single-center Prospective Cohort Study to Evaluate the Efficacy and Safety of Methotrexate Injection (Metoject(R)) in Subjects with Moderateto-Severe Immune Checkpoint Inhibitor-Related Psoriasis' on June 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Zhongshan Hospital Affiliated to Fudan University

Condition: Immune-related Checkpoint Inhibitor-Related Psoriasis

Intervention: Control Group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-10-20

Target Sample Size: Control Group:36;Methotrexate Injection Group:50;

Countries of Recruitmen...